Our SynBio panel had a really popular turn-out at Labiotech Refresh. Chaired by Cathal Garvey, the Program Director at IndieBio EU, we had some very diverse leaders in the field present, from Biohackers to the CEO of Biofuel giant, Deinove.
Asides Cathal, on the panel we had Axel Polack, a General Partner at the Joint Polish Investment Fund, Thomas Ladrain, the founder and CEO of La Paillasse and the bio-ink startup Pili, and Emmanuel Petiot, CEO of Deinove.
I found this panel particularly interesting, and there were lots of good questions from the audience. Cathal was also particularly apt at steering the conversation to cover many areas in the industry, from small-scale biotinkering (biohacking) to industrial scale synthetic biology.
As he explained, most of the principles for SynBio were in the 80’s and 90’s (kicked off by the founding of Genentech). But progress was relatively slow.
So what was missing then?